Spectral AI, Inc. is a predictive artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid health care providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 16.61% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 29.58M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 29.58M.
Fairly Valued
The company’s latest PE is -2.79, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 3.87M shares, decreasing 21.33% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 623.05K shares of this stock.